Ground-Breaking Insights into the Power of Testosterone

Share with your friends:

In a revolutionary leap for women’s health, Newson Health proudly stands as the first UK organization to reveal groundbreaking research on the multifaceted benefits of testosterone, transcending its traditional association solely with sexual function. Ground-Breaking Insights into the Power of Testosterone

Led by Menopause Specialist Dr. Louise Newson, a comprehensive retrospective observational study has illuminated the untapped potential of testosterone. Scheduled for presentation at the Annual European Congress on Menopause and Andropause in Florence, Italy, on May 5th, this research heralds a new era in understanding the critical role of testosterone in women’s well-being.

🔍 Key Findings: Unlocking Testosterone’s Hidden Potential

In a study encompassing 905 women aged 45 and over, researchers analyzed data from those prescribed testosterone cream or gel at the Newson Health Menopause and Wellbeing Clinic between August 2021 and February 2022. The results are nothing short of revolutionary:

  • Mood Magic: Testosterone exhibited a remarkable 47% improvement in mood-related symptoms, providing relief from anxiety and irritability commonly experienced during menopause.
  • Enhanced Focus: Concentration and memory saw a notable boost, with a 34% improvement, offering a potential remedy for cognitive challenges faced by menopausal women.
  • Holistic Benefits: Beyond sexual function, testosterone contributed to a 37% overall improvement in sexual function scores, emphasizing its comprehensive impact on women’s health.

🎉 A Beacon of Hope for Women Worldwide

Dr. Louise Newson, founder of Newson Health and the balance app, emphasized the scandalous oversight of testosterone not being licensed for women in the UK. She envisions these findings as a catalyst for global research, a pioneering step towards recognizing testosterone’s broader benefits for women grappling with perimenopausal and menopausal symptoms.

🚀 Pioneering Advances in Testosterone Products

As the 13 million perimenopausal and menopausal women in the UK anticipate this groundbreaking revelation, the news aligns with advancements in testosterone products. The application for Marketing Authorisation Application (MAA) of the testosterone cream AndroFeme and the upcoming clinical trial for a testosterone patch for post-menopausal women mark a pivotal moment in women’s healthcare.

📈 Charting the Course Forward

While acknowledging the observational nature of the study, Dr. Newson highlights the pressing need for further research. She envisions a future where testosterone becomes an integral component of Hormone Replacement Therapy (HRT), offering holistic relief for women navigating the perimenopausal and menopausal journey.

💡 Testosterone: Beyond Libido to Total Well-Being

As a biologically active hormone produced in higher quantities than estrogen in younger women, testosterone’s decline in midlife poses challenges. Despite not being currently licensed for women in the UK, many healthcare professionals prescribe it ‘off-license,’ backed by safety considerations akin to various other medications.

💬 Join the Conversation

Newson Health invites dialogue, collaboration, and a collective push towards understanding and embracing testosterone as a vital element in women’s health. With ongoing partnerships with academics and clinicians globally, Newson Health is committed to pioneering research that transforms the narrative around testosterone, enhancing the lives of women everywhere. 🌐💪

For those eager to delve deeper into the study, the findings poster is available for download here. Let’s embark on this transformative journey toward redefining women’s health together! 🌺🔬✨

Like what we do? then please consider subscribing to us https://whatsgoingonireland.ie/subscribe-landing-page/

TikTok for more https://www.tiktok.com/@whatsgoingonireland?lang=en

Ground-Breaking Insights into the Power of Testosterone

Leave a Comment

Your email address will not be published. Required fields are marked *